CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue

CME Group Inc. (NASDAQ:CME) is one of the best fintech stocks to invest in. On February 4, CME Group announced financial results for 2025, underscored by annual revenues of $6.5 billion. Average daily volume/AD grew 6% to 28.1 million contracts, driven by a 12% increase in commodities trading and a 5% rise in financials. The company reported record annual adjusted operating income, net income, and adjusted EPS of $11.20.

Q4 for CME Group Inc. (NASDAQ:CME) was particularly strong, marking the highest fourth-quarter volume on record with an ADV of 27.4 million contracts. Cryptocurrency trading emerged as a major growth engine, with Q4 volume surging 92% to over $13 billion in daily notional value. Beyond transaction fees, market data revenue also hit a record $803 million for the year, supported by a 3.5% price increase and expanding global demand. Non-US participation continued to scale, with ADV from Asia rising 18% and EMEA rising 6% during the quarter.

For 2026, CME Group is focused on several capital-efficiency and technology initiatives, including the launch of a new securities clearing house following SEC approval and the ongoing migration to Google Cloud. The company is also expanding into prediction markets and exploring tokenized collateral to enhance client margins.

CME Group Inc. (NASDAQ:CME), together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

While we acknowledge the potential of CME as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the

.